Risorse - Poster scientifici

Automated Triplexed Hepatocyte-Based Viability and CYP1A and CYP3A Induction Assays in 96- and 384-well Microplates


Related Products: Lavatore dispensatore EL406

February 02, 2011


Authors: Brad Larson, Peter Banks, BioTek Instruments, Inc., Winooski, VT; James Cali, Promega Corporation, Madison, WI; Timothy Moeller, Celsis In Vitro Technologies, Baltimore, MD

 Promega Logo             Celsis Logo



The ability to monitor CYP induction, inhibition, and cytotoxicity by xenobiotics using an automated, multiplexed format can decrease workloads and increase data confi dence. Here we demonstrate the ability to monitor CYP1A and -3A induction, combined with a cytotoxicity measurement, from a single well using cryopreserved human hepatocytes. The assay procedure was automated in 96- and 384-well formats, including cell manipulations, compound titration and transfer, and reagent dispensing, using simple, yet robust robotic instrumentation. EC50 values were derived for multiple known inducers of CYP1A and -3A from an 11-point curve. Induction and toxicological responses in the triplex system were validated based on consistency with conventional single parameter assays. Validation and pharmacology data confi rm that multiplexed cell-based CYP assays can simplify workload, save time and effort, and generate the data needed from today’s ADME/Tox laboratory.

biotek instruments

EL406, Synergy H4,  Precision